Filing Details
- Accession Number:
- 0001179110-18-008963
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-06-22 17:41:52
- Reporting Period:
- 2018-06-20
- Accepted Time:
- 2018-06-22 17:41:52
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1235010 | Momenta Pharmaceuticals Inc | MNTA | Biological Products, (No Disgnostic Substances) (2836) | 043561634 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1415739 | Elizabeth Stoner | C/O Momenta Pharmaceuticals, Inc. 301 Binney Street Cambridge MA 02142 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2018-06-20 | 5,734 | $0.00 | 28,541 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2018-06-21 | 2,288 | $22.20 | 26,253 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Acquisiton | 2018-06-20 | 8,855 | $0.00 | 8,855 | $22.30 |
| Common Stock | Restricted Stock Units | Acquisiton | 2018-06-20 | 4,356 | $0.00 | 4,356 | $0.00 |
| Common Stock | Restricted Stock Units | Disposition | 2018-06-20 | 5,734 | $0.00 | 5,734 | $0.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 8,855 | 2028-06-20 | No | 4 | A | Direct | |
| 4,356 | No | 4 | A | Direct | ||
| 0 | No | 4 | M | Direct |
Footnotes
- This transaction was effected pursuant to a Rule 10b5-1 trading plan.
- This transaction was executed in multiple trades at prices ranging from $22.15 to $22.20. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- Represents an option granted by the Company pursuant to the Company's 2013 Incentive Award Plan. The stock option will vest and become exercisable on the first anniversary of the grant date, subject to Dr. Stoner's continued service to the Company.
- Each restricted stock unit represents a contingent right to receive one share of MNTA common stock.
- Represents 4,356 restricted stock units, awarded pursuant to the Company's 2013 Incentive Award Plan, 100% of the restricted stock units shall vest on the first anniversary of the grant date, subject to Dr. Stoner's continued service to the Company.
- Restricted Stock Units convert into common stock on a one-for-one basis.
- Subject to certain criteria, 100% of the restricted stock units shall vest on the first anniversary of the grant date.
Billionaire Hedge Funds
